In the context of obesity, increased leptin signaling between ASCs and breast cancer cells represents an area where the proliferative and immunomodulatory effects of ASCs contribute to an environment that permits neoplastic growth. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.